NCI renews MUSC Hollings support grant with “outstanding” rating

As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
What the scientific method obscures

We recently had the privilege of contributing to a CBS Sunday Morning story on the ongoing crisis in the federal support for research in general and cancer research in particular.

July 03, 2025

Vol.51 No.26

By George J. Weiner and Elizabeth M. Jaffee

In Brief

Besim Ogretmen named assistant vice president for research at MUSC

Besim Ogretmen was named assistant vice president for research in the Office of the Vice President for Research at the Medical University of South Carolina.

July 03, 2025

Vol.51 No.26

In Brief

RWJBarnabas Health, Rutgers Cancer Institute welcomes first patients

RWJBarnabas Health and Rutgers Cancer Institute officially opened the doors of the 12-story, 520,000 square-foot, state-of-the-art Jack & Sheryl Morris Cancer Center—the state’s only freestanding, comprehensive cancer hospital, one of just 13 in the nation.

June 27, 2025

Vol.51 No.25

In Brief

Peter Voorhees named associate director of clinical research at Wake Forest

Peter Voorhees was promoted to associate director of clinical research and will oversee clinical research for Atrium Health Wake Forest Baptist Comprehensive Cancer Center, as well as all processes related to clinical protocol and data management and protocol review and monitoring system.

June 20, 2025

Vol.51 No.24

In Brief

Samra Turajlić appointed director of Cancer Research UK Manchester Institute

Samra Turajlić was appointed the director of the Cancer Research UK Manchester Institute.

June 20, 2025

Vol.51 No.24

Podcast The Directors

The Directors: Candace Johnson and Jonathan Friedberg on living through uncertainty at NCI, payment woes
Directors of two neighboring cancer centers in Upstate New York will face challenges, but “we’ll get through it”

Candace S. Johnson leads America’s oldest cancer research center and Jonathan W. Friedberg leads the newest NCI-designated center. Their catchment areas are contiguous, their faculty and staff members collaborate often, and together their institutions embody the culture of NCI-designated cancer centers.

June 13, 2025

Vol.51 No.23

By Paul Goldberg

NCI renews MUSC Hollings support grant with “outstanding” rating

YOU MAY BE INTERESTED IN

As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
What the scientific method obscures

Besim Ogretmen named assistant vice president for research at MUSC

RWJBarnabas Health, Rutgers Cancer Institute welcomes first patients

Peter Voorhees named associate director of clinical research at Wake Forest

Samra Turajlić appointed director of Cancer Research UK Manchester Institute

The Directors: Candace Johnson and Jonathan Friedberg on living through uncertainty at NCI, payment woes
Directors of two neighboring cancer centers in Upstate New York will face challenges, but “we’ll get through it”

Renew today!

Subscriber content

Never miss an issue!

Login

NCI renews MUSC Hollings support grant with “outstanding” rating

YOU MAY BE INTERESTED IN

As cancer scientists, we must change how we engage with the public on the impact of NIH cutsWhat the scientific method obscures

Besim Ogretmen named assistant vice president for research at MUSC

RWJBarnabas Health, Rutgers Cancer Institute welcomes first patients

Peter Voorhees named associate director of clinical research at Wake Forest

Samra Turajlić appointed director of Cancer Research UK Manchester Institute

The Directors: Candace Johnson and Jonathan Friedberg on living through uncertainty at NCI, payment woesDirectors of two neighboring cancer centers in Upstate New York will face challenges, but “we’ll get through it”

Never miss an issue!

Login

As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
What the scientific method obscures

The Directors: Candace Johnson and Jonathan Friedberg on living through uncertainty at NCI, payment woes
Directors of two neighboring cancer centers in Upstate New York will face challenges, but “we’ll get through it”